Drug of choice: Ilumya (tildrakizumab-asmn)
1. For this drug, determine the classification of the drug. If
it is a combination drug, what are the classifications of each of
the two combined drugs?
2. If it is a combination drug, what was the purpose of
combining them?
3. Describe the classification(s)— uses/implications,
pharmacodynamics, pharmacokinetics, safe dosage range(s), general
side effects, concerns or warnings of using this drug and your drug
specifically. If it is a combined drug, discuss both of the...